PENGEMBANGAN KIT DIAGNOSTIK BERBASIS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) SEBAGAI ALAT EVALUASI KEBERHASILAN VAKSINASI COVID-19
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) virus. The disease was first detected in 2019 and now it has spread to more than 228 countries. COVID-19 data in Indonesia shows that this disease infected more tha...
Saved in:
Main Author: | Dwi Artameutia S, Nandya |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/67729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
PENGEMBANGAN KIT DIAGNOSTIK ANTI-HBSAG KUANTITATIF BERBASIS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
by: Khairunnisa -
QUANTITATIVE HEPATITIS B DIAGNOSTIC KIT DEVELOPMENT BASED ON ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
by: Rahmadini, Hafiza -
The value of enzyme-linked immunosorbent assay (ELISA) for diagnosis of human trichinosis
by: Morakote N., et al.
Published: (2014) -
Evaluation of enzyme-linked immunosorbent assay (ELISA) test in the diagnosis of tuberculous meningitis.
by: N. Poungvarin, et al.
Published: (2018) -
Feasibility study of a biochip for mumps virus enzyme-linked immunosorbent assay (ELISA)
by: Woon, Fung Peng.
Published: (2008)